Hematology Amy Peterson
2018
In 2018, Hematology Amy Peterson earned a total compensation of $3.4M as Chief Medical Officer Immuno, oncology at BeiGene, Ltd., a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,500 |
|---|---|
| Option Awards | $2,199,983 |
| Salary | $425,000 |
| Stock Awards | $549,851 |
| Other | $8,250 |
| Total | $3,395,584 |
Peterson received $2.2M in option awards, accounting for 65% of the total pay in 2018.
Peterson also received $212.5K in non-equity incentive plan, $425K in salary, $549.9K in stock awards and $8.3K in other compensation.
Rankings
In 2018, Hematology Amy Peterson's compensation ranked 3,357th out of 14,244 executives tracked by ExecPay. In other words, Peterson earned more than 76.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,357 out of 14,244 | 76th |
Division Manufacturing | 1,241 out of 5,765 | 79th |
Major group Chemicals And Allied Products | 432 out of 2,128 | 80th |
Industry group Drugs | 355 out of 1,817 | 81st |
Industry Pharmaceutical Preparations | 272 out of 1,391 | 80th |
Source: SEC filing on April 29, 2019.
Peterson's colleagues
We found five more compensation records of executives who worked with Hematology Amy Peterson at BeiGene, Ltd. in 2018.